Pancreatic Cancer Research

ResearcherTufts UniversityNo recent work listed

Martin D. Goodman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8226-8339; OpenAlex author ID A5102882579. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 5

  1. Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surger… Co-author PMID 32982620↗
  2. Adjuvant therapy for pancreatic cancer. Co-author DOI 10.6092/1590-8577/2324↗
  3. Adjuvant treatment for pancreatic cancer. Last author DOI 10.6092/1590-8577/2692↗
  4. New developments in the management of borderline resectable pancreatic cancer. Co-author DOI 10.6092/1590-8577/1473↗
  5. Adjuvant therapy of pancreatic cancer. Co-author DOI 10.6092/1590-8577/1461↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Wasif Saif · 5 shared papers, 2012–2020 · strength 0.42
  2. Ronald R. Salem · 1 shared paper, 2020 · strength 0.16
  3. John Ng · 2 shared papers, 2012–2013 · strength 0.10
  4. Vladimir Daoud · 1 shared paper, 2014 · strength 0.07
  5. Jaya Sharma · 1 shared paper, 2013 · strength 0.05
  6. Chakra P. Chaulagain · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.